quality life index atopic dermatitis qoliad disease specific patient reported outcome measures impact atopic dermatitis ad given patients quality questionnaire patients age maximum score restricted yes higher scores qoliad indicate greater negative influence disease quality qoliad developed funded novartis pharma ag switzerland produced several countries content derived qualitative interviews patients uk italy netherlands initial version measure produced uk english translated netherlands italy germany france us spanish version later developed tests implemented validate measure administered patients country finalize institutions involved development qoliad galen research united kingdom erasmus university netherlands university greifswald germany university verona italy chu bichat france health research spain novartis pharmaceuticals corporation qoliad translated seven languages uk include german spanish japanese qoliad also utilized assess effectiveness new treatments atopic dermatitis includes studies looking educational topical httpsenwikipediaorgwikiqualityoflifeindexforatopicdermatitis